✦ LIBER ✦

Oral fluoropyrimidines in the treatment of colorectal cancer

✍ Scribed by N.J Meropol

Book ID: 117665932
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 97 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(98)00226-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral Fluoropyrimidines in the Treatment

Oral Fluoropyrimidines in the Treatment of Colorectal Cancer

✍ D. Bissett; F. Ahmed; H. McLeod; J. Cassidy 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Oral Fluoropyrimidine Treatment of Color

Oral Fluoropyrimidine Treatment of Colorectal Cancer

✍ Cathy Eng; Hedy L. Kindler; Richard L. Schilsky 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 152 KB

Oxaliplatin plus Oral Fluoropyrimidines

Oxaliplatin plus Oral Fluoropyrimidines in Colorectal Cancer

✍ Axel Grothey; Matthew P. Goetz 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 132 KB

Capecitabine, a new oral fluoropyrimidin

Capecitabine, a new oral fluoropyrimidine for the treatment of colorectal cancer

✍ Francesco Di Costanzo; Andrea Sdrobolini; Silvia Gasperoni 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Capecitabine (Xeloda) ® was developed as a tumour-selective fluoropyrimidine carbamate to achieve higher intratumoural 5-FU level and lower toxicity than 5-FU. Capecitabine passes unchanged through the gastrointestinal tract and is metabolised in the liver to 5%-deoxy-5-fluorocytidine (5%-DFCR). Her

An oral fluoropyrimidine prodrug with ac

An oral fluoropyrimidine prodrug with activity in colorectal cancer

✍ Ronald M. Bukowski 📂 Article 📅 2001 🏛 Current Science Inc. 🌐 English ⚖ 56 KB

Integrating the oral fluoropyrimidines i

Integrating the oral fluoropyrimidines into the management of advanced colorectal cancer

✍ D Cunningham; R.D James 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB